Navigation Links
Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
Date:10/31/2007

PARIS and LAUSANNE, Switzerland, Oct. 31 /PRNewswire/ -- Ipsen (Euronext: FR0010259150; IPN) and Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in oncology and serious medical conditions today announced the extension of their agreement, whereby Ipsen exclusively in-licenses know-how and new patent applications for the commercialization rights of Decapeptyl(R) (triptorelin pamoate) in the world excluding North America, and some other countries (Sweden, Israel, Iran and Japan). This new agreement will last for a minimum of 5 years, with a 2 year termination period, after the patent expiry of the current marketed formulations in July 2010. It further enables Ipsen to access future sustained-release formulations of Decapeptyl(R)(1) developed by Debiopharm, among which a 6 month sustained release formulation that has completed phase III clinical trials and is expected to be filed by Debiopharm in 2008.

Ipsen will thus be able to propose Decapeptyl(R) in a wider range of treatment regimens, allowing further adaptation to the therapeutic needs of cancer patients.

Under the terms of this agreement, the royalties paid by Ipsen to Debiopharm until July 2010 will remain unchanged. After this date, Ipsen will continue to pay royalties on its sales of all formulations of Decapeptyl(R). Ipsen and Debiopharm will share development costs of the 6 month formulation once it is approved in one major country in Europe. Ipsen will thereafter exclusively purchase Decapeptyl(R) (triptorelin pamoate) 6 month from Debiopharm's cGMP(2) FDA inspected development and production facility in Martigny, Switzerland, whilst the royalty rate for the entire franchise will stand in the mid-single digit range.

Stephane Thiroloix, Executive Vice President, Corporate Development of Ipsen said "We are very pleased to have extended our relationship with our long-standing partner Debiopharm. This agreement should further enable Ipsen to
'/>"/>

SOURCE Debiopharm Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Ranbaxy to Market Debiopharms New Drug in India
2. Medicare Drug Deadline not to be extended
3. Liver key to extending life
4. Regular exercise linked to extended menstrual cycles
5. Even mid-life diet change can extend life
6. Extended Therapy for Blood Clots
7. Friendship can extend lifespan
8. Genes to Extend Longevity Discovered
9. India extends National TB Control Program
10. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
11. Drug Courts In Europe Extended For Three More Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... Knoxville, TN (PRWEB) March 06, 2015 ... on January 1, 2015, there has been an overwhelming ... implement an efficient and compliant CCM program. The ... clarification on several matters. , PYA’s updated white ... ”—incorporates this new guidance into a detailed, yet practical ...
(Date:3/6/2015)... First Choice Emergency Room opened its ... located at 13351 W. Bowles Avenue, Littleton, Colorado and is ... 24-7 to provide the highest quality emergency medical care to ... First Choice Emergency Room Littleton. , First Choice ... Denver Chamber of Commerce and a medical community open house ...
(Date:3/6/2015)... La (PRWEB) March 06, 2015 Many ... function despite medical therapy. If you (or someone you ... to knee osteoarthritis, you may be interested in the ... Covington Orthopedic announced today that he is one of ... Cytori Therapeutics to begin enrolling subjects as part of ...
(Date:3/6/2015)... Atlanta, GA (PRWEB) March 06, 2015 ... algorithms, announced the release of a Clostridium Difficile ... outpatient providers. The C Diff use case is ... capabilities that span hospital acquired infections, chronic conditions, ... phenotype platform, the C Diff solution flags at ...
Breaking Medicine News(10 mins):Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... 9 While people across the country scrutinize,the unemployed mother ... 26, eyes also must turn to the fertility doctor who ... 33-year-old mother, Nadya Suleman, the same physician,treated her for each ... that in her last IVF treatment, six embryos were transferred ...
... RoundTable Healthcare Partners,("RoundTable"), an operating-oriented private equity ... that Sandy Thompson has become a,Senior Transaction Advisor ... Thompson will,assist RoundTable in the identification of new ... Thompson has 17 years of experience in the ...
... Throughout February, Kaz, Inc., the makers of Honeywell ... "National Care About Your Indoor Air" month. ... National Parent Teacher Organization and the Healthy House ... is working to educate consumers about the importance ...
... Some patients who suffer a stroke as a result ... benefit from a clot-busting drug nine or more hours after ... online edition of Radiology . , "Stroke is ... the study,s lead author, William A. Copen, M.D., Director of ...
... Buying an outing, like going to the beach, boosts ... -- Although everyone knows that money can,t buy ... increase your well-being, new research suggests. , In a ... to rate a recent purchase intended to make them ...
... 9 The nation,s first - and only - program ... non-contact anterior cruciate ligament (ACL) tears among female high school ... in Rochester, New York. The program, called PEP ... the most serious knee injuries that can sideline athletic careers ...
Cached Medicine News:Health News:Fertility Expert Calls Birth of Octuplets 'Criminal' 2Health News:RoundTable Healthcare Partners Names Sandy Thompson as Senior Transaction Advisor 2Health News:Honeywell Home Comfort Products' Second Annual 'National Care About Your Indoor Air' Month 2Health News:Honeywell Home Comfort Products' Second Annual 'National Care About Your Indoor Air' Month 3Health News:Stroke therapy window might be extended past nine hours for some 2Health News:Experiences Bring More Joy Than Possessions Do 2Health News:Experiences Bring More Joy Than Possessions Do 3Health News:ACL Injury Prevention Program is First in Nation to Tackle Growing Problem 2Health News:ACL Injury Prevention Program is First in Nation to Tackle Growing Problem 3
(Date:3/6/2015)... marzo de 2015 TeraRecon, ( www.terarecon.com ... de imagen médica, fortalece su posición dentro del ... Randolph Sternberg como director de ventas y ... operaciones. Logo - http://photos.prnewswire.com/prnh/20150303/179359LOGO ... de las ventas y desarrollo empresarial en Europa, ...
(Date:3/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rvhg65/european_patient ) ... Handling Equipment Market by Product, by Type of Care, ... report to their offering. The ... at a double-digit CAGR of 11.4% to reach $5,150.2 ... rising geriatric population, increasing incidences of lifestyle diseases, and ...
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
Breaking Medicine Technology:TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 2European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2
... (NASDAQ: AMRI ), a global contract services organization ... as part of its ongoing global operations review to improve ... its European operations focused on a reduction of the workforce ... at its Budapest, Hungary operation. As a ...
... Jan. 9, 2012  Xenon today announced a strategic alliance ... RO, ROG; OTCQX: RHHBY), to discover and develop compounds ... "We are delighted to be collaborating with ... "Genentech is among the world,s leading biotech companies and ...
Cached Medicine Technology:AMRI Announces Review of Its Hungary Operation 2AMRI Announces Review of Its Hungary Operation 3Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics 2
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... Systems non-adhesive sealing method maintains ... Surgrery (HALS) procedures, allowing the ... palpate throughout. Because HALS requires ... cm, patients experience less trauma ...
... a Hand Assisted Laparoscopic Surgery (HALS) device ... hand may facilitate the procedure, and for ... in colorectal, urological and general surgical procedures. ... of pneumoperitoneum and abdominal access for the ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
Medicine Products: